BACKGROUND: A proportion of children with sickle-cell disease (SCD) demonstrate clinical findings consistent with the diagnosis of asthma. These children are at increased risk of complications, including acute chest syndrome. OBJECTIVE: To assess lung function and symptoms of asthma in children with SCD in Blantyre, Malawi. DESIGN: Twenty-five children aged 7-16 years with electrophoretically confirmed SCD were recruited to undergo spirometry and questionnaire screening of asthma symptoms. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio were compared with local and international reference ranges. Symptoms were assessed using the International Study of Asthma and Allergies in Childhood questionnaire. RESULTS: Mean spirometric indices, represented as Z-scores derived from international reference ranges, were low: FEV1 -1.64 (95%CI -2.04 to -1.23), FVC -1.49 (95%CI -1.90 to -1.09), FEV1/FVC -0.39 (95%CI -0.76 to -0.03). Comparison with local reference ranges, represented as percentage of predicted value, revealed similar impairments: FEV1 86.9 (95%CI 81.1 to 92.7), FVC 89.0 (95%CI 83.5 to 94.4), FEV1/FVC ratio 97.7 (95%CI 95.4 to 99.9). The prevalence of wheeze was 16.7%. CONCLUSION: We present spirometric abnormalities suggestive of restrictive lung disease with no evidence of obstructive defects or increased prevalence of wheeze.
BACKGROUND: A proportion of children with sickle-cell disease (SCD) demonstrate clinical findings consistent with the diagnosis of asthma. These children are at increased risk of complications, including acute chest syndrome. OBJECTIVE: To assess lung function and symptoms of asthma in children with SCD in Blantyre, Malawi. DESIGN: Twenty-five children aged 7-16 years with electrophoretically confirmed SCD were recruited to undergo spirometry and questionnaire screening of asthma symptoms. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio were compared with local and international reference ranges. Symptoms were assessed using the International Study of Asthma and Allergies in Childhood questionnaire. RESULTS: Mean spirometric indices, represented as Z-scores derived from international reference ranges, were low: FEV1 -1.64 (95%CI -2.04 to -1.23), FVC -1.49 (95%CI -1.90 to -1.09), FEV1/FVC -0.39 (95%CI -0.76 to -0.03). Comparison with local reference ranges, represented as percentage of predicted value, revealed similar impairments: FEV1 86.9 (95%CI 81.1 to 92.7), FVC 89.0 (95%CI 83.5 to 94.4), FEV1/FVC ratio 97.7 (95%CI 95.4 to 99.9). The prevalence of wheeze was 16.7%. CONCLUSION: We present spirometric abnormalities suggestive of restrictive lung disease with no evidence of obstructive defects or increased prevalence of wheeze.
Authors: R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk Journal: Am J Respir Crit Care Med Date: 2000-01 Impact factor: 21.405
Authors: J David Holtzclaw; Daniel Jack; Samuel M Aguayo; James R Eckman; Jesse Roman; Lewis L Hsu Journal: Am J Respir Crit Care Med Date: 2003-12-18 Impact factor: 21.405
Authors: M A Jenkins; J R Clarke; J B Carlin; C F Robertson; J L Hopper; M F Dalton; D P Holst; K Choi; G G Giles Journal: Int J Epidemiol Date: 1996-06 Impact factor: 7.196
Authors: B J Brabin; P D Prinsen-Geerligs; F H Verhoeff; K A Fletcher; L H E Chimsuku; B M Ngwira; O J Leich; R L Broadhead Journal: Ann Trop Med Parasitol Date: 2004-01
Authors: O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug Journal: N Engl J Med Date: 1994-06-09 Impact factor: 91.245
Authors: Rashida A Ferrand; Sujal R Desai; Charlotte Hopkins; Caroline M Elston; Susan J Copley; Kusum Nathoo; Chiratidzo E Ndhlovu; Shungu Munyati; Richard D Barker; Robert F Miller; Tsitsi Bandason; Athol U Wells; Elizabeth L Corbett Journal: Clin Infect Dis Date: 2012-04-02 Impact factor: 20.999
Authors: Cirlene de Lima Marinho; Maria Christina Paixão Maioli; Jorge Luis Machado do Amaral; Agnaldo José Lopes; Pedro Lopes de Melo Journal: PLoS One Date: 2017-12-08 Impact factor: 3.240
Authors: Cirlene de Lima Marinho; Maria Christina Paixão Maioli; Jorge Luis Machado do Amaral; Agnaldo José Lopes; Pedro Lopes de Melo Journal: PLoS One Date: 2019-03-07 Impact factor: 3.240